With over 15 years of experience in health economics and outcomes research (HEOR), I am a leader in the field of oncology HEOR. As the head of US Oncology HEOR at Astellas Pharma, I oversee the development and execution of HEOR strategies and studies to support the value proposition and market access of Astellas' oncology portfolio. I also collaborate with cross-functional teams, external partners, and key stakeholders to ensure alignment and integration of HEOR evidence and insights across the product lifecycle. Previously, I was the director of health economics at GE Healthcare, where I led the design and implementation of health economic models and analyses for diagnostic imaging and digital health solutions. I have a MBA from Northwestern University - Kellogg School of Management, a MS in Computer Information Systems from Northwestern University, and a Pharm.D. from University of California, San Francisco. I have multiple publications and presentations in peer-reviewed journals and conferences, and I am an active member of professional associations and committees. I am passionate about improving patient outcomes and healthcare quality through innovative and rigorous HEOR methodologies and applications. I value collaboration, diversity, and learning, and I seek to contribute to the advancement of the oncology HEOR field and the Astellas Pharma organization.